Maxia Strategies GmbH

Swiss Biotech Association

Member

Maxia Strategies specializes in creating efficient product development strategies and providing supporting regulatory services. Our primary focus is helping small to medium-sized enterprises maximize the value of their products throughout their development lifecycle.

http://www.maxiastrategies.com
+41 61 511 4560
office@maxiastrategies.com
Dr. Karl E. Burgin

Location

Gellertstrasse 4, 4052 Basel, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2010
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

LATAM Pharma Innovative Ventures AG

LATAM Pharma offers made-to-measure solutions of immunization to public and private markets in Latin American and Caribbean countries.
6300 Zug

Member

SPINOFRIN

Spinofrin is a CDMO specialized in particle engineering. Its unique and patented Spray Flash Evaporation (SFE) technology achieves submicron dry powders through a continuous single step process. Spinofrin is developing an R&D and an industrial plant to manufacture cGMP samples.
1020 Renens

Member

Zeta CH AG

<strong>One-stop shop for the pharma and biotech industry</strong> The ZETA Group, with 900 highly qualified employees and 14 subsidiaries worldwide, specializes in the design, manufacturing, automation, digitalization, and qualification of customized biopharmaceutical facilities for aseptic process solutions.
5606 Dintikon

Member